Literature DB >> 26377307

The sum of all fears: conceptual challenges with measuring fear of cancer recurrence.

Daniel S J Costa1, Allan Ben Smith2, Joanna E Fardell3,4.   

Abstract

Fear of cancer recurrence (FCR) is increasingly recognised as a major concern for people with cancer once active treatment is completed. Several instruments have been designed to assess FCR; however, no gold standard has emerged. Many instruments conceptualise FCR as a multidimensional construct. However, this potentially conflates FCR as an outcome with its antecedents and consequences. This is problematic when an aggregate of distinct dimensions is calculated, as is commonly recommended. For example, the total score on the Fear of Cancer Recurrence Inventory is an aggregate of items from seven sub-scales: triggers, severity, psychological distress, coping strategies, functioning impairments, insight and reassurance. Similarly, the total score on the Fear of Progression Questionnaire is an aggregate of affective reaction, partnership/family, work and loss of autonomy. Arguably, the severity and affective reaction domains represent fear, and the other sub-scales represent related concepts, rather than "dimensions" of FCR. The total score represents a combination of concepts whose meaning is unclear. The same total score could be produced by patients with very different experiences, and patients with the same level of fear could have very different total scores. Therefore, we argue that although the level of FCR may be determined by a complex network of antecedents and modifiers and have variable consequences, FCR itself may be a simple concept, which can be assessed using a smaller number of items. Conceptual clarity in its research infancy should prevent FCR becoming a construct that is vaguely operationalised and interpreted.

Entities:  

Keywords:  Conceptual; Fear of Cancer Recurrence Inventory; Fear of Progression Questionnaire; Fear of cancer recurrence; Questionnaires

Mesh:

Year:  2015        PMID: 26377307     DOI: 10.1007/s00520-015-2943-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  6 in total

1.  The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence.

Authors:  Suzanne M Johnson Vickberg
Journal:  Ann Behav Med       Date:  2003

Review 2.  Fear of cancer recurrence: a systematic literature review of self-report measures.

Authors:  Belinda Thewes; Phillis Butow; Robert Zachariae; Soren Christensen; Sébastien Simard; Carolyn Gotay
Journal:  Psychooncology       Date:  2011-10-21       Impact factor: 3.894

3.  The Concerns About Recurrence Questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors.

Authors:  Belinda Thewes; Robert Zachariae; Søren Christensen; Tine Nielsen; Phyllis Butow
Journal:  J Cancer Surviv       Date:  2014-08-19       Impact factor: 4.442

4.  Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire.

Authors:  Peter Herschbach; Petra Berg; Andrea Dankert; Gabriele Duran; Ursula Engst-Hastreiter; Sabine Waadt; Monika Keller; Robert Ukat; Gerhard Henrich
Journal:  J Psychosom Res       Date:  2005-06       Impact factor: 3.006

5.  Screening and comorbidity of clinical levels of fear of cancer recurrence.

Authors:  Sébastien Simard; Josée Savard
Journal:  J Cancer Surviv       Date:  2015-01-21       Impact factor: 4.442

6.  Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence.

Authors:  Sébastien Simard; Josée Savard
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

  6 in total
  13 in total

1.  Fear of Cancer Recurrence and Inhibited Disclosure: Testing the Social-Cognitive Processing Model in Couples Coping With Breast Cancer.

Authors:  Emily C Soriano; Amy K Otto; Stefanie T LoSavio; Christine Perndorfer; Scott D Siegel; Jean-Philippe Laurenceau
Journal:  Ann Behav Med       Date:  2021-03-20

2.  Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.

Authors:  Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow
Journal:  Support Care Cancer       Date:  2018-06-07       Impact factor: 3.603

3.  Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.

Authors:  Louise Sharpe; J Turner; J E Fardell; B Thewes; A B Smith; J Gilchrist; J Beith; A Girgis; S Tesson; S Day; K Grunewald; P Butow
Journal:  J Cancer Surviv       Date:  2019-07-25       Impact factor: 4.442

4.  Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey.

Authors:  Clément Magnani; Allan Ben Smith; Dominique Rey; Aline Sarradon-Eck; Marie Préau; Marc-Karim Bendiane; Anne-Déborah Bouhnik; Julien Mancini
Journal:  J Cancer Surviv       Date:  2022-03-23       Impact factor: 4.442

5.  Checking Behavior, Fear of Recurrence, and Daily Triggers in Breast Cancer Survivors.

Authors:  Emily C Soriano; Rosmeiry Valera; Elizabeth C Pasipanodya; Amy K Otto; Scott D Siegel; Jean-Philippe Laurenceau
Journal:  Ann Behav Med       Date:  2019-03-01

Review 6.  Anxiety and Depression in Cancer Survivors.

Authors:  Jean C Yi; Karen L Syrjala
Journal:  Med Clin North Am       Date:  2017-08-18       Impact factor: 5.456

7.  Associations among physical symptoms, fear of cancer recurrence, and emotional well-being among Chinese American breast cancer survivors: a path model.

Authors:  Dalnim Cho; Qiao Chu; Qian Lu
Journal:  Support Care Cancer       Date:  2017-12-14       Impact factor: 3.603

8.  The fear of cancer recurrence and progression in patients with pancreatic cancer.

Authors:  Esther N Pijnappel; Willemieke P M Dijksterhuis; Mirjam A G Sprangers; Simone Augustinus; Judith de Vos-Geelen; Ignace H J T de Hingh; Izaak Q Molenaar; Olivier R Busch; Marc G Besselink; Johanna W Wilmink; Hanneke W M van Laarhoven
Journal:  Support Care Cancer       Date:  2022-02-15       Impact factor: 3.359

9.  iCanADAPT Early protocol: randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors -vs- treatment as usual.

Authors:  M J Murphy; J M Newby; P Butow; L Kirsten; K Allison; S Loughnan; M A Price; J Shaw; H Shepherd; J Smith; G Andrews
Journal:  BMC Cancer       Date:  2017-03-15       Impact factor: 4.430

10.  Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7.

Authors:  G M Humphris; E Watson; M Sharpe; G Ozakinci
Journal:  Health Qual Life Outcomes       Date:  2018-02-09       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.